🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is the first clinical experience in Japan with GSK1120212, a novel MEK...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-24
Trial ID
NCT01324258
Treatments Being Tested
MEK112111 is a dose-escalation, Phase IB, open-label, single-arm, multi-cen...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-12
Trial ID
NCT01428427
Treatments Being Tested
This was an open-label study to permit subjects with solid tumors or leukem...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-11-02
Trial ID
NCT01376310
This is a Phase IIa, open-label, single-arm, multi-center study to evaluate...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-09-19
Trial ID
NCT01943864
Treatments Being Tested
GSK1120212 is a potent and highly selective inhibitor of MEK phosphorylatio...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08
Trial ID
NCT01231581
Treatments Being Tested
Approximately 90% of children with malignant brain tumors that have recurre...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2018-03-05
Trial ID
NCT03434262
Treatments Being Tested